Patients with SSBP1 mutations typically suffer from optic atrophy and have also been reported to experience neurological dysfunction mainly affecting the visual system (retinopathy, foveopathy, ptosis, ophthalmoplegia) and auditory system (sensorineural hearing loss) [46,162,163,164,165]. Here, SSBP1 is linked to hereditary optic atrophy.